Literature DB >> 7836919

Upregulation of surface markers on dying thymocytes.

H Kishimoto1, C D Surh, J Sprent.   

Abstract

Using terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) to detect cells undergoing early apoptosis, we have defined the surface markers expressed on CD4+CD8+ thymocytes undergoing spontaneous or steroid-induced apoptosis in tissue culture. Some surface markers, e.g., CD4, CD8, and heat stable antigen, are downregulated on apoptotic thymocytes. Surprisingly, however, other markers are upregulated; this applies to T cell receptor beta/CD3, CD69, and CD25 expression. Upregulation of these markers is restricted to a discrete subset of apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7836919      PMCID: PMC2191870          DOI: 10.1084/jem.181.2.649

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Clonal deletion of immature CD4+8+ thymocytes in suspension culture by extrathymic antigen-presenting cells.

Authors:  W Swat; L Ignatowicz; H von Boehmer; P Kisielow
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

2.  CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody.

Authors:  T Tadakuma; H Kizaki; C Odaka; R Kubota; Y Ishimura; H Yagita; K Okumura
Journal:  Eur J Immunol       Date:  1990-04       Impact factor: 5.532

3.  Peptide sequences of T-cell receptor delta and gamma chains are identical to predicted X and gamma proteins.

Authors:  W Born; C Miles; J White; R O'Brien; J H Freed; P Marrack; J Kappler; R T Kubo
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

4.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death.

Authors:  J J Cohen; R C Duke
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

5.  Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.

Authors:  P Portoles; J Rojo; A Golby; M Bonneville; S Gromkowski; L Greenbaum; C A Janeway; D B Murphy; K Bottomly
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

6.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

Authors:  I Nicoletti; G Migliorati; M C Pagliacci; F Grignani; C Riccardi
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

7.  Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor.

Authors:  I Jung-Testas; E E Baulieu
Journal:  Exp Cell Res       Date:  1983-08       Impact factor: 3.905

8.  Studies on T cell maturation on defined thymic stromal cell populations in vitro.

Authors:  E J Jenkinson; G Anderson; J J Owen
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

9.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo.

Authors:  H Kosaka; C D Surh; J Sprent
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  30 in total

1.  Decrease in cell surface sialic acid in etoposide-treated Jurkat cells and the role of cell surface sialidase.

Authors:  Y Azuma; A Taniguchi; K Matsumoto
Journal:  Glycoconj J       Date:  2000-05       Impact factor: 2.916

2.  Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients.

Authors:  L A Chau; S Rohekar; J-J Wang; D Lian; S Chakrabarti; L Zhang; R Zhong; J Madrenas
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection.

Authors:  Christophe Viret; Xin He; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

4.  Rabies virus infects mouse and human lymphocytes and induces apoptosis.

Authors:  M I Thoulouze; M Lafage; J A Montano-Hirose; M Lafon
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia.

Authors:  G T Belz; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

6.  Heat-shock protein expression on the membrane of T cells undergoing apoptosis.

Authors:  F Poccia; P Piselli; S Vendetti; S Bach; A Amendola; R Placido; V Colizzi
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

7.  Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis.

Authors:  Christophe Préhaud; Stéphanie Lay; Bernhard Dietzschold; Monique Lafon
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Without peripheral interference, thymic deletion is mediated in a cohort of double-positive cells without classical activation.

Authors:  Yifan Zhan; Jared F Purton; Dale I Godfrey; Timothy J Cole; William R Heath; Andrew M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

9.  Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide.

Authors:  C N Levelt; E Mizoguchi; X Huang; R Zacks; A K Bhan; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76.

Authors:  Martha S Jordan; Jennifer E Smith; Jeremy C Burns; Jessica-Elise T Austin; Kim E Nichols; Anna C Aschenbrenner; Gary A Koretzky
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.